Paolo Paoletti, CEO of GammaDelta Therapeutics celebrated in the 2019 Maserati 100 Innovators of the year award.
News 7th Oct 2017

GammaDelta Therapeutics highlighted in CNBC Europe News

CNBC Europe highlighted GammaDelta Therapeutics in a recent report based on the interdisciplinary research activities undertaken at the Francis Crick Institute. Prof. Adrian Hayday, a scientific founder of GammaDelta Therapeutics, summarized the basic research undertaken within his laboratories, including those at the Francis Crick Institute, which contributed to the launch of the spin-out company GammaDelta Therapeutics. The report noted the successful $100m collaboration between GammaDelta Therapeutics and Takeda to support the development of novel immunotherapies.